Catalyst Wire Dossier Catalyst Wire Dossier

Seladelpar

seladelpar · Gilead Sciences
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Seladelpar, covering 2018-05-18 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) [Phase 3]

See pricing